Bak BH3

Bak BH3 peptide is a synthetic peptide fragment derived from the BH3 domain of the pro-apoptotic Bak protein, a key member of the Bcl-2 family involved in the regulation of programmed cell death. As a highly conserved motif, the BH3 domain is essential for mediating interactions between pro- and anti-apoptotic proteins, thereby influencing mitochondrial outer membrane permeabilization and subsequent apoptotic signaling. The Bak BH3 peptide is widely utilized in biochemical and cell biology research to dissect apoptotic pathways, probe protein-protein interactions within the Bcl-2 family, and investigate the molecular mechanisms underlying cellular fate decisions. Its defined sequence and well-characterized binding properties make it a valuable tool for researchers seeking to elucidate the precise roles of Bcl-2 family proteins in apoptosis and mitochondrial dynamics.

Apoptosis research: The Bak BH3 peptide is extensively employed as a molecular probe to study the mechanisms of apoptosis, particularly the initiation of mitochondrial outer membrane permeabilization. By mimicking the native BH3 domain, the peptide enables researchers to selectively activate or inhibit specific Bcl-2 family interactions, providing insights into the balance between pro- and anti-apoptotic signals within cells. This approach supports the dissection of apoptotic pathways in a controlled and reproducible manner, facilitating a deeper understanding of cell death regulation in various physiological and pathological contexts.

Protein-protein interaction studies: In vitro binding assays and structural analyses frequently utilize the Bak BH3 peptide to characterize the affinity and specificity of interactions between Bcl-2 family members. The peptide's defined sequence allows for quantitative assessment of binding kinetics, structural conformations, and competitive inhibition in fluorescence polarization, isothermal titration calorimetry, and surface plasmon resonance experiments. Such studies are instrumental in mapping the interaction landscape of apoptotic regulators and identifying potential modulators of these critical protein networks.

Drug discovery and inhibitor screening: The Bak BH3 peptide serves as a reference ligand or positive control in high-throughput screening platforms designed to identify small molecules or peptides that modulate Bcl-2 family interactions. By providing a reliable benchmark for binding to anti-apoptotic proteins such as Bcl-xL and Mcl-1, it enables the validation and optimization of candidate inhibitors targeting the BH3-binding groove. This application is particularly valuable for the development of novel apoptosis-modulating agents in preclinical research and mechanistic studies.

Structural biology: Researchers employ the Bak BH3 peptide in crystallography and nuclear magnetic resonance (NMR) studies to resolve the three-dimensional structures of BH3 domain complexes with their protein partners. The peptide facilitates the formation of stable complexes suitable for structural elucidation, thereby advancing knowledge of the molecular determinants governing BH3-mediated recognition and binding. Insights gained from these studies inform the rational design of synthetic analogs and peptidomimetics with tailored binding properties.

Mitochondrial function assays: Functional studies of mitochondrial physiology often incorporate the Bak BH3 peptide to induce or modulate mitochondrial outer membrane permeabilization in isolated organelles or permeabilized cells. By directly triggering the release of cytochrome c and other apoptogenic factors, the peptide provides a controlled means to investigate the downstream consequences of mitochondrial disruption, including caspase activation, metabolic shifts, and changes in cellular redox status. These assays contribute to a comprehensive understanding of mitochondrial involvement in apoptosis and related cellular processes.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

4. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling